Centessa Pharmaceuticals Poster Presentation at the American College of Neuropsychopharmacology (ACNP) 64th Annual Meeting Jan 14, 2026 Supporting Materials CNT-9982, an orexin receptor 2 agonist, enhances wakefulness in marmosets, and in the Wistar Kyoto rat model of major depressive disorder, normalizes the arousal state phenotype and alleviates behavioral despair 4.4 MB
CNT-9982, an orexin receptor 2 agonist, enhances wakefulness in marmosets, and in the Wistar Kyoto rat model of major depressive disorder, normalizes the arousal state phenotype and alleviates behavioral despair 4.4 MB
